GB1211
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GB1211, covering 2021-02-23 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma [Phase 2]